Explosion on Passenger Train in Quetta Injures Over 30 Security Concerns May Impact Pakistans Investment Climate
Billionaire Bill Ackmans Pershing Square Adds Over 2 Billion in Microsoft Shares
University of Manchester to Offer Work Placements Across All Degree Programs
Oura Files Confidentially for IPO Expanding Health Wearable Market Reach
Nvidia Earnings Set to Test Market Sentiment as Investors Focus on China Strategy and Political Commentary
Global Stocks Rise Bond Yields Fall as USIran Talks Show Signs of Progress
CZNC Q1 2026 Earnings Massive EPS Miss Shocks Analysts Stock Holds Steady
Banc of California Inc BANC Q1 2026 Earnings EPS Surpasses Estimates Amid Solid Operating Performance
UPS Q1 2026 Earnings Earnings Beat Estimates Amid Operational Efficiency Focus
TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines
Fractyl Health Q1 2026 Earnings Narrowerthanexpected loss fails to lift stock as pipeline progress awaited
CNSP Q1 2026 Earnings WiderthanExpected Loss Highlights ClinicalStage Cash Burn
Lakeshore Acquisition III LCCC Holds Steady at 1036 Amid SPAC Market Uncertainty
Blackrock MuniHoldings New Jersey Quality Fund MUJ Edges Higher Amid Steady Demand
Cardlytics CDLX Inches Up as Key Support Holds A Closer Look at the Recovery
Putnam Municipal Opportunities Trust PMO Climbs 063 as Income Demand Supports Price
Fifth Third Bancorp Preferred Series K FITBO Holds Near Support as Yield Attracts Income Seekers
FMAO Q1 2026 Earnings EPS Surpasses Estimates Amidst Challenging Interest Rate Environment
SITM Q1 2026 Earnings EPS Surges Past Estimates with 22 Beat
FLWS Q1 2026 Earnings Deep EPS Miss Fails to Deter Investors as Stock Edges Higher
MO Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick
XCF Global Inc SAFX Q1 2026 Earnings Narrow EPS Beat Sparks Cautious Optimism
Digi Power X Inc DGXX Q3 2025 Earnings Losses Narrow as Operational Focus Intensifies
Eli Lilly Reports Positive Phase 3 Results for Obesity Treatment Retatrutide Showcasing Significant Weight Reduction
Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues
Processa Pharmaceuticals PCSA Surges 575 as Shares Test Key Resistance Level